Syndax Pharmaceuticals SNDX
NASDAQ SNDX
$9.81 +0.32 (+3.32%)
As of: Nov 11, 2026 · 3:38 PM EST

Syndax Pharmaceuticals (SNDX) Return on Capital Employed [ROCE] (2016 - 2026)

Updated

Syndax Pharmaceuticals (SNDX) posted Return on Capital Employed [ROCE] of -30.95% for Q3 2026, up 35.80 percentage points from -66.75% a year earlier and up 8.80 percentage points from the prior quarter.

Analysis

Syndax Pharmaceuticals (SNDX) Return on Capital Employed [ROCE] (2016 - 2026) Analysis & Trends

For FY2025, Syndax Pharmaceuticals' Return on Capital Employed [ROCE] came in at -53.85%, up 6.24 percentage points from FY2024.

  • Annual Return on Capital Employed [ROCE] shows a five-year change of -10.08 percentage points (FY2020 to FY2025).
  • In prior years, Syndax Pharmaceuticals' Return on Capital Employed [ROCE] was -60.09% in FY2024 (-13.82 pp), -46.27% in FY2023 (-12.12 pp), -34.15% in FY2022 (-41.55 pp) and 7.40% in FY2021 (+51.16 pp).
  • The Q3 2026 figure stands as the highest quarterly Return on Capital Employed [ROCE] since Q3 2022.
  • On a year-over-year basis, Return on Capital Employed [ROCE] has increased in each of the last five quarters, with an average year-over-year change of +6.92 percentage points over the last eight quarters.
  • The strongest year-over-year quarter for Return on Capital Employed [ROCE] in the past five years was Q4 2021, with a gain of 40.40 percentage points; the weakest was Q3 2023, with a drop of 47.75 percentage points.
  • According to Business Quant data, Return on Capital Employed [ROCE] for the three prior quarters was -39.75% (Q2 2026), -53.86% (Q1 2026) and -64.92% (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 35.41%
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 17.52%
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 21.60%
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 4.65%
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 9.91%
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 17.37%
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -6.15%
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 11.32%
10 Syndax Pharmaceuticals 854.00 Mn -867.10 Mn 69.30 Mn -30.95%
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 -30.95%
Jun 30, 2026 -39.75%
Mar 31, 2026 -53.86%
Dec 31, 2025 -64.92%
Sep 30, 2025 -66.75%
Jun 30, 2025 -67.08%
Mar 31, 2025 -58.47%
Dec 31, 2024 -72.00%
Sep 30, 2024 -81.94%
Jun 30, 2024 -61.60%
Mar 31, 2024 -49.98%
Dec 31, 2023 -51.33%
Sep 30, 2023 -51.60%
Jun 30, 2023 -41.61%
Mar 31, 2023 -35.38%
Dec 31, 2022 -38.00%
Sep 30, 2022 -3.86%
Jun 30, 2022 0.30%
Mar 31, 2022 4.08%
Dec 31, 2021 8.10%
API Access

Syndax Pharmaceuticals Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=SNDX&period=max&api_key=YOUR_API_KEY